Anakinra for Preterm Infants Pilot

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

March 21, 2024

Study Completion Date

March 31, 2025

Conditions
Prematurity; ExtremeInflammation
Interventions
DRUG

Anakinra

Anakinra will be given to enrolled infants starting in the first 24hrs of life for the first 3 weeks of life.

Trial Locations (2)

1023

Starship Children's Hospital, Te Whatu Ora - Health New Zealand, Grafton

3168

Monash Health, Clayton

All Listed Sponsors
collaborator

Monash University

OTHER

collaborator

Hudson Institute of Medical Research

UNKNOWN

collaborator

Te Whatu Ora - Health New Zealand

UNKNOWN

collaborator

University of Auckland, New Zealand

OTHER

lead

Monash Medical Centre

OTHER